Open AccessA Brief Note on Mucormycosis: The So-Called Black Fungus Causing Co-Infection with the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
Author(s) -
Afia Ibnat Ava,
AUTHOR_ID,
Abrar Hamim Fayz,
Shahreen Sultana,
Priangka Bhattacharya Pingki,
Rashed Noor,
AUTHOR_ID,
AUTHOR_ID,
AUTHOR_ID,
AUTHOR_ID
Publication year - 2021
Publication title -
journal of bacteriology and mycology
Language(s) - English
Resource type - Journals
ISSN - 2471-0172
DOI - 10.26420/jbacteriolmycol.2021.1178
Subject(s) - mucormycosis , pandemic , medicine , covid-19 , coronavirus , middle east respiratory syndrome coronavirus , fungus , intensive care medicine , biology , disease , surgery , infectious disease (medical specialty) , botany
In association to the ongoing COVID-19 pandemic caused by the Severe Acute Respiratory Coronavirus 2 (SARS-CoV-2), the recent onset of fungal co-infection (Mucormycosis), generally known as black fungus, have made the COVID-19 situation clinically more complicated with increased mortality. Such fungal co-infection has been noticed in the severe COVID-19 patients especially who had the history of diabetes; and used steroid drugs. The fungal infection causes serious damage to the COVID-19 patients; and in many instances surgery of the affected region becomes mandatory in addition the prescribed but limited anti-fungal drug. Present review briefly discussed the clinical consequences of the black fungus co-infection in the COVID-19 patients based on the recently published literatures.